Publications:38
Accepting New Patients
Mount Sinai Doctors
Accepting New PatientsDavid F Yankelevitz, MD
Nuclear Medicine, Radiology
No Patient Experience Ratings
Book an Appointment
About Me
Dr. David Yankelevitz is a Professor of Radiology and the Director of the Lung Biopsy Service at the Icahn School of Medicine. He is a world-recognized expert on Fine Needle Aspirations (FNAs) of lung nodules and he has developed one of the largest FNA practices in the United States -- performing over 10,000 FNA procedures over the course of his career.
Also a researcher, Dr. Yankelevitz’s main academic interest is in the evaluation of treatments for early-diagnosed lung cancer; and he has been the Co-Principal Investigator of the Initiative for Early Lung Cancer Research on Treatment (IELCART) since its inception in 2015. As part of that program, and in order to advance the diagnosis and treatment of lung cancer, one of his contributions was to develop the idea of evaluating lung nodule growth rates to create benchmark measurements that assess cancer risk. In addition to the IELCART research, Yankelevitz has, for the past 20 years, been a Co-Principal Investigator of the International Early Lung Cancer Action Program (I-ELCAP) – a lung cancer screening study which, to date, has screened over 79,000 people in 10 countries around the world; and he has been Principal Investigator on four National Cancer Institute (NCI) grants.
Dr. Yankelevitz has co-authored over 300 peer-reviewed articles and book chapters, and he has trained 40 Research Fellows in thoracic imaging. Prior to joining the faculty at Mount Sinai in 2010, he was a Professor of Radiology at Weill Cornell Medical College in New York City.
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Cancer, Image Analysis, Imaging, Lung
About Me
Dr. David Yankelevitz is a Professor of Radiology and the Director of the Lung Biopsy Service at the Icahn School of Medicine. He is a world-recognized expert on Fine Needle Aspirations (FNAs) of lung nodules and he has developed one of the largest FNA practices in the United States -- performing over 10,000 FNA procedures over the course of his career.
Also a researcher, Dr. Yankelevitz’s main academic interest is in the evaluation of treatments for early-diagnosed lung cancer; and he has been the Co-Principal Investigator of the Initiative for Early Lung Cancer Research on Treatment (IELCART) since its inception in 2015. As part of that program, and in order to advance the diagnosis and treatment of lung cancer, one of his contributions was to develop the idea of evaluating lung nodule growth rates to create benchmark measurements that assess cancer risk. In addition to the IELCART research, Yankelevitz has, for the past 20 years, been a Co-Principal Investigator of the International Early Lung Cancer Action Program (I-ELCAP) – a lung cancer screening study which, to date, has screened over 79,000 people in 10 countries around the world; and he has been Principal Investigator on four National Cancer Institute (NCI) grants.
Dr. Yankelevitz has co-authored over 300 peer-reviewed articles and book chapters, and he has trained 40 Research Fellows in thoracic imaging. Prior to joining the faculty at Mount Sinai in 2010, he was a Professor of Radiology at Weill Cornell Medical College in New York City.
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Cancer, Image Analysis, Imaging, Lung
Clinical Focus
- Biopsy
- CT Scan (General)
- Cancer
- Lung Cancer
Education
MD, SUNY Downstate Health Sciences University - College of Medicine
Internship, Internal Medicine
Staten Island University Hospital
Residency, Radiology, General
Long Island College Hospital
Residency, Nuclear Medicine
New York Presbyterian Hospital-Weill Cornell
Fellowship, Radiology, General
New York Presbyterian Hospital-Weill Cornell
Certifications
Nuclear Medicine
American Board of Radiology
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Radiology Associates1176 5th Ave., MC Level, New York, NY, 10029
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Management of Small Histologic and Cytologic Specimens in the Molecular Era. Anjali Saqi, David F. Yankelevitz.
- Understanding the core result of the national lung screening trial. David F. Yankelevitz, James P. Smith. New England Journal of Medicine
- A new platform for quantitative CT imaging dose optimization. Rick Avila, Karthik Krishnan, Brian Helba, David Yankelevitz, Eric Hanson.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Yankelevitz during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Carestream Health
- LungLife AI
- HeartLung
- Median Technology
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- HeartLung
- Accumetra LLC
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Yankelevitz during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Carestream Health
- LungLife AI
- HeartLung
- Median Technology
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- HeartLung
- Accumetra LLC
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.